← Back to Clinical Trials
Recruiting NCT05978336

NCT05978336 SuPA Mobility: Supporting Physical Activity for Mobility in Mobility-Limited Older Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05978336
Status Recruiting
Phase —
Sponsor University of British Columbia
Condition Limitation, Mobility
Study Type INTERVENTIONAL
Enrollment 290 participants
Start Date 2023-09-05
Primary Completion 2027-06-30

Eligibility & Interventions

Sex All sexes
Min Age 70 Years
Max Age 89 Years
Study Type INTERVENTIONAL
Interventions
Health Coaching ProgramHealth Education Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 290 participants in total. It began in 2023-09-05 with a primary completion date of 2027-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this randomized controlled trial is to investigate the effectiveness of a health-coaching intervention to improve physical activity in older adults with limited mobility when compared to a control, health education group.

Eligibility Criteria

Inclusion Criteria: * scored ≤ 9/12 on the SPPB * are able to complete the 400-m walk in ≤ 15 minutes without sitting or physical assistance from another person or walker (use of cane is acceptable) * scored 22/30 or higher on the Mini-Mental State Examination (MMSE) * have no significant functional impairment as indicated by a score of 6/8 or higher on the Lawton and Brody Instrumental Activities of Daily Living Scale * are able to safely engage in MVPA as indicated by the PAR-Q+ and by the family or study physician as necessary * are community-dwelling * are able to provide written informed consent. Exclusion Criteria: * are diagnosed with dementia or stroke * self-report engaging in MVPA ≥ 10 minutes per week in the prior 3 months * are unable to understand, speak, and read English proficiently

Contact & Investigator

Central Contact

Nathan Wei, B.Sc.

✉ nathan.wei@ubc.ca

📞 604-875-4111

Principal Investigator

Teresa Liu-Ambrose, PhD

PRINCIPAL INVESTIGATOR

University of British Columbia

Frequently Asked Questions

Who can join the NCT05978336 clinical trial?

This trial is open to participants of all sexes, aged 70 Years or older, up to 89 Years, studying Limitation, Mobility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05978336 currently recruiting?

Yes, NCT05978336 is actively recruiting participants. Contact the research team at nathan.wei@ubc.ca for enrollment information.

Where is the NCT05978336 trial being conducted?

This trial is being conducted at Vancouver, Canada.

Who is sponsoring the NCT05978336 clinical trial?

NCT05978336 is sponsored by University of British Columbia. The principal investigator is Teresa Liu-Ambrose, PhD at University of British Columbia. The trial plans to enroll 290 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology